Krystal Biotech (NASDAQ: KRYS) net income
Krystal Biotech reported a net profit of $204.8m for fiscal 2025, 129.7% more than in fiscal 2024 ($89.2m). Its net margin was 52.6%. Earnings per share were $7.08.
Krystal Biotech has grown its net income for 2 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. It reported a loss in 7 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $204.8m | +129.7% | 52.6% | $7.08 |
| 2024 | $89.2m | +715.6% | 30.7% | $3.12 |
| 2023 | $10.9m | — | 21.6% | $0.40 |
| 2022 | −$140.0m | — | — | −$5.49 |
| 2021 | −$69.6m | — | — | −$3.13 |
| 2020 | −$32.2m | — | — | −$1.71 |
| 2019 | −$19.1m | — | — | — |
| 2018 | −$10.9m | — | — | — |
| 2017 | −$7.9m | — | — | — |
| 2016 | −$1.2m | — | — | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Krystal Biotech net income compared with its sector
By net income for its latest fiscal year, Krystal Biotech ranks 88th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Krystal Biotech, 52.6%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 86th | Indivior Pharmaceuticals | $210.0m | 16.9% |
| 87th | Option Care Health | $207.6m | 3.7% |
| 88th | Krystal Biotech | $204.8m | 52.6% |
| 89th | Doximity | $196.1m | 30.4% |
| 90th | PACS Group | $191.5m | 3.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Krystal Biotech
- How much did Krystal Biotech earn in fiscal 2025?
- Krystal Biotech reported a net profit of $204.8m for fiscal 2025. In fiscal 2024 it reported a net profit of $89.2m.
- What are the earnings per share of Krystal Biotech?
- They were $7.08 in fiscal 2025, compared with $3.12 in fiscal 2024.
- What is the net margin of Krystal Biotech?
- In fiscal 2025 its net profit was 52.6% of its revenue.
- What was the most profitable year for Krystal Biotech?
- Of its last 10 fiscal years, fiscal 2025, with $204.8m.
- Where does Krystal Biotech rank in its sector by net income?
- It ranks 88th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Krystal Biotech come from?
- From the annual report (Form 10-K) that Krystal Biotech files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Krystal Biotech files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Krystal Biotech: the Krystal Biotech page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.